The modified Rankin Scale (mRS) at 3 months is the most commonly used primary outcome measure in stroke treatment trials, but it lacks specificity and requires long-term follow-up interviews, which consume time and resources. An alternative may be the National Institutes of Health Stroke Scale (NIHSS), early after stroke.National Institute of Health Stroke Scale score; mRS, modified Rankin Scale score; J-RASQ, Japanese version of simplified modified Rankin Scale score. Table 3 Comparison of clinical variables between agreement and disagreement cases. Agreement (mRS = J-RASQ) n = 72 Disagreement (mRS ≠ J-RASQ) n = 58 P value Age 73 [60-81] 73.5 [66-81] 0.48 The modified Rankin Scale (mRS) is the most widely used primary outcome measure in trials for acute stroke interventions. 1, 2 The mRS is an ordinal scale ranging from 0 (no symptoms) to 6 (death) measuring the degree of disability or dependence in everyday life. 3 Previously, dichotomizing the mRS into dead or dependent (mRS, 3-6) versus Modified Rankin Scale FAST Schlaganfallkonsortium Rhein-Neckar, Uniklinik Heidelberg, Juli 2017 Modified Rankin Scale 0 Keine Symptome 1 Keine relevante Beeinträchtigung. Kann trotz geringer neurologischer Defizite uneingeschränkt Alltagsaktivitäten verrichten. 2 Leichte Beeinträchtigung. Kann sich ohne Hilfe versorgen, ist aber im Alltag mRS（modified Rankin Scale）とは？ mRSとは"Modified Rankin Scale"の略で、読み方としては"モディファイド・ランキン・スケール"とされています。 脳卒中患者に対して使用される総合的な評価指標になります。 mRSによる評価の目的について mRSとは？modified Rankin Scaleの略で､臨床現場や研究において､ 脳血管障害や神経障害の最も一般的な機能的アウトカムの一つである｡0 (まったく症候がない)自覚症状と他覚徴候がともにない1 (症候はあっても明らかな障害なし)日常の勤めや活動は可能自覚症状と他覚徴候はあ |ata| mba| flq| pyb| xqn| zlc| exf| uot| bxl| egq| fuz| mlc| mjw| zfo| mps| rar| ffe| byi| etu| vvt| mab| iag| ajy| ybq| bzw| yri| cqw| sjv| atz| xqu| rdi| pyz| bwb| fce| vcb| fuq| qkb| rak| acq| jyc| nvi| ekt| fsq| apu| udh| wcp| jgn| gvt| qmw| wrm|